A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features | MicrobiomeTrials← Back to trialsNCT06999941
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2025-04-24Est. Completion: 2026-08-30
Enrollment target: 50 participants Locations- Shanghai general hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Other microbiome trials you might be interested in
Psoriatic Arthritis
While many studies examine Nonalcoholic fatty liver disease (NAFLD), little is known about its progression to high-risk …
San Diego, United StatesEst. completion Sep 1, 2027
Skin Barrier to Water LossPASI /SCORAD Index
This randomized, double-blind, placebo-controlled clinical trial is designed to evaluate the safety and efficacy of topi…
Shenzhen, ChinaCompleted Mar 5, 2026